| Metric | H1 2026 | H1 2025 |
|---|---|---|
| Revenue | 1.9 | 2.0 |
| Gross profit | 0.5 | 0.3 |
| Profit before tax | -8.1 | 0.7 |
| Net income | -8.0 | 0.7 |
| EPS (diluted, $ a share) | $-852.55 | $7,397.70 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Revenue, year on year | -4.7% |
|---|---|
| Gross margin | 24.1% |
| Operating margin | -184.3% |
Source
Read the filing ↗
6-K filed with the SEC, NASDAQ: NIVF. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
NewGenIvf Group Ltd: key numbers
- Share price
- $0.2050Close, Nov 16
- Sector
- Industrial Applications and Services
- Industry
- Services-Misc Health & Allied Services, NECSIC 8090
Today's reference numbers, updated daily. Not a valuation or a recommendation.